3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Lung Squamous Cell Carcinoma
1
Breast Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Exome
1
Bevacizumab
1
89Zr-bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Neurofibromatosis 2
×
Exome
×
Clear all
NCT03210285
2018-07-23
NF2
University Hospital Tuebingen
Completed
70 enrolled